Natco Pharma Limited — Others, 29-05-2025: Copy of Newspaper Publication

Natco Pharma has announced a board meeting to consider the financial results for the quarter and half-year. Consolidated revenue increased to ₹4429.5 Cr from ₹3998.8 Cr year-on-year, with profit before tax rising to ₹2291.4 Cr from ₹1673.5 Cr. Profit after tax grew to ₹1885.4 Cr compared to ₹1388.3 Cr. Standalone revenue climbed to ₹4094.5 Cr from ₹3568.9 Cr, profit before tax reached ₹2226 Cr, and net profit was ₹1850.4 Cr. Earnings per share on a consolidated basis rose to ₹105.26. The results reflect strong revenue growth and solid profitability.